Dong-Jun Lin

402 total citations
18 papers, 338 citations indexed

About

Dong-Jun Lin is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Dong-Jun Lin has authored 18 papers receiving a total of 338 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 5 papers in Cancer Research and 3 papers in Oncology. Recurrent topics in Dong-Jun Lin's work include Bioactive Natural Diterpenoids Research (5 papers), Peroxisome Proliferator-Activated Receptors (5 papers) and Histone Deacetylase Inhibitors Research (3 papers). Dong-Jun Lin is often cited by papers focused on Bioactive Natural Diterpenoids Research (5 papers), Peroxisome Proliferator-Activated Receptors (5 papers) and Histone Deacetylase Inhibitors Research (3 papers). Dong-Jun Lin collaborates with scholars based in China. Dong-Jun Lin's co-authors include Jiajun Liu, Renwei Huang, Peiqing Liu, Xudong Li, Xiangyuan Wu, Qu Lin, Ruozhi Xiao, Jun Peng, Min Huang and Yi He and has published in prestigious journals such as SHILAP Revista de lepidopterología, Annals of Oncology and American Journal of Hematology.

In The Last Decade

Dong-Jun Lin

18 papers receiving 333 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dong-Jun Lin China 9 253 83 70 42 39 18 338
Jiajun Liu China 14 412 1.6× 153 1.8× 91 1.3× 49 1.2× 36 0.9× 25 520
Tengyang Ni China 12 231 0.9× 83 1.0× 88 1.3× 92 2.2× 36 0.9× 31 392
Angela Cisneros United States 8 237 0.9× 64 0.8× 24 0.3× 57 1.4× 31 0.8× 13 395
Rebecca P. Danam United States 6 267 1.1× 85 1.0× 26 0.4× 49 1.2× 17 0.4× 8 409
Fu‐Gang Duan China 10 219 0.9× 80 1.0× 30 0.4× 52 1.2× 45 1.2× 14 390
An-Sik Chung South Korea 7 264 1.0× 64 0.8× 19 0.3× 31 0.7× 21 0.5× 8 388
Ruozhi Xiao China 10 365 1.4× 216 2.6× 44 0.6× 38 0.9× 20 0.5× 23 451
Yi Yuan China 9 311 1.2× 167 2.0× 58 0.8× 86 2.0× 18 0.5× 17 466
Chandra Sekhar Chirumamilla Belgium 9 161 0.6× 44 0.5× 61 0.9× 38 0.9× 13 0.3× 11 306
Hanchi Miao China 7 234 0.9× 39 0.5× 21 0.3× 48 1.1× 63 1.6× 7 345

Countries citing papers authored by Dong-Jun Lin

Since Specialization
Citations

This map shows the geographic impact of Dong-Jun Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dong-Jun Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dong-Jun Lin more than expected).

Fields of papers citing papers by Dong-Jun Lin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dong-Jun Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dong-Jun Lin. The network helps show where Dong-Jun Lin may publish in the future.

Co-authorship network of co-authors of Dong-Jun Lin

This figure shows the co-authorship network connecting the top 25 collaborators of Dong-Jun Lin. A scholar is included among the top collaborators of Dong-Jun Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dong-Jun Lin. Dong-Jun Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Mou, Xiao, et al.. (2019). Prognostic impact of prognostic nutritional index in advanced (stage IIIB/IV) non-small cell lung cancer patients. Neoplasma. 66(6). 971–977. 6 indexed citations
2.
Liu, Xiaoyun, et al.. (2018). A Case of Unicentric Castleman Disease and Langerhans Cell Histiocytosis: Two Entities in One Lymph Node. Clinical Laboratory. 64(11+12/2018). 1 indexed citations
3.
Fan, Ruifang, Xiaoyan Guo, Ying Lu, et al.. (2016). Zoledronic acid overcomes adriamycin resistance in acute myeloid leukemia cells by promoting apoptosis. Molecular Medicine Reports. 14(6). 5660–5666. 3 indexed citations
4.
Fan, Ruifang, et al.. (2016). RUNX3 plays an important role in As2O3-induced apoptosis and allows cells to overcome MSC-mediated drug resistance. Oncology Reports. 36(4). 1927–1938. 2 indexed citations
5.
Xiao, Ruozhi, et al.. (2013). Inhibition of extracellular signal-regulated kinase activity by sorafenib increases sensitivity to DNR in K562 cells. Oncology Reports. 29(5). 1895–1901. 4 indexed citations
6.
Li, Xudong, et al.. (2013). Acute Pleural and Pericardial Effusion Induced by Chemotherapy in Treating Chronic Myelocytic Leukemia. Clinical Laboratory. 60(05/2014). 853–7. 2 indexed citations
7.
Zhang, Xiangzhong, Aihua Yin, Dong-Jun Lin, et al.. (2012). Analyzing Gene Expression Profile in K562 Cells Exposed to Sodium Valproate Using Microarray Combined with the Connectivity Map Database. SHILAP Revista de lepidopterología. 2012. 1–8. 8 indexed citations
8.
Liu, Xiangfu, Ruifang Fan, Zi‐Jie Long, et al.. (2011). RUNX3 is involved in caspase-3-dependent apoptosis induced by a combination of 5-aza-CdR and TSA in leukaemia cell lines. Journal of Cancer Research and Clinical Oncology. 138(3). 439–449. 7 indexed citations
9.
Liu, Jiajun, Yan Xu, Peiqing Liu, et al.. (2011). Inhibition of Lymphoma Cell Proliferation by Peroxisomal Proliferator-Activated Receptor-γ Ligands via Wnt Signaling Pathway. Cell Biochemistry and Biophysics. 62(1). 19–27. 29 indexed citations
10.
Liu, Jiajun, Wenda Liu, Hongzhi Yang, et al.. (2010). Inactivation of PI3k/Akt signaling pathway and activation of caspase-3 are involved in tanshinone I-induced apoptosis in myeloid leukemia cells in vitro. Annals of Hematology. 89(11). 1089–1097. 49 indexed citations
11.
Lin, Dong-Jun, et al.. (2009). Mechanistic study of peroxisome proliferator-activated receptor γ (PPARγ) agonist induced apoptosis of NB4 cells.. Journal of Tropical Medicine. 9(1). 4–6. 1 indexed citations
12.
Liu, Jiajun, Renwei Huang, Dong-Jun Lin, et al.. (2006). Antiproliferation effects of oridonin on HPB-ALL cells and its mechanisms of action. American Journal of Hematology. 81(2). 86–94. 20 indexed citations
13.
14.
Liu, Jiajun, Dong-Jun Lin, Peiqing Liu, et al.. (2006). Induction of apoptosis and inhibition of cell adhesive and invasive effects by tanshinone IIA in acute promyelocytic leukemia cells in vitro. Journal of Biomedical Science. 13(6). 813–823. 57 indexed citations
15.
Liu, Jiajun, Huiling Lü, Renwei Huang, et al.. (2005). Peroxisome proliferator activated receptor-γ ligands induced cell growth inhibition and its influence on matrix metalloproteinase activity in human myeloid leukemia cells. Cancer Chemotherapy and Pharmacology. 56(4). 400–408. 44 indexed citations
16.
Liu, Jiajun, Renwei Huang, Dong-Jun Lin, et al.. (2005). Apoptotic effect of oridonin on NB4 cells and its mechanism. Leukemia & lymphoma. 46(4). 593–597. 13 indexed citations
17.
Huang, Runqing, Dong-Jun Lin, Jun Peng, et al.. (2005). Expression of survivin and bax/bcl-2 in peroxisome proliferator activated receptor-γ ligands induces apoptosis on human myeloid leukemia cells in vitro. Annals of Oncology. 16(3). 455–459. 59 indexed citations
18.
Liu, Jiajun, Renwei Huang, Dong-Jun Lin, et al.. (2004). Oridonin-induced apoptosis of Jurkat cells and its mechanism. Comparative Clinical Pathology. 13(2). 65–69. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jiajun Liu Breakdown of academic impact, for papers by Tengyang Ni Breakdown of academic impact, for papers by Angela Cisneros Breakdown of academic impact, for papers by Rebecca P. Danam Breakdown of academic impact, for papers by Fu‐Gang Duan Breakdown of academic impact, for papers by An-Sik Chung Breakdown of academic impact, for papers by Ruozhi Xiao Breakdown of academic impact, for papers by Yi Yuan Breakdown of academic impact, for papers by Chandra Sekhar Chirumamilla Breakdown of academic impact, for papers by Hanchi Miao
Rankless by CCL
2026